Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Epicrispr Biotechnologies, a clinical-stage company pioneering gene-modulating therapies, today announced that Amber Salzman, Ph.D., Chief Executive Officer, will present at the 44th Annual J.P.

Ryan, a leading global tax services and software provider, is pleased to announce it has been named one of the Best Places to Work in Pennsylvania, marking the 14th year the Firm has been honored for ...

At Korea Institute of Science and Technology (KIST), where research areas include materials, robotics and artificial intelligence, the team within its CJLab function were involved in Cas9 research.

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...

A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...

On a video call in early September, Sarah Tabrizi first saw the data that she and other researchers studying Huntington’s ...

Ark sold shares of Iridium Communications ( IRDM) worth over $14 million with transactions across ARKK, ARKQ and ARKX, ...